Platelet activation correlates with disease severity in bronchiectasis

R. Méndez (Valencia, Spain), A. Moscardó (Valencia, Spain), A. Latorre (Valencia, Spain), A. Piró (Valencia, Spain), P. Gonzalez-Jimenez (Valencia, Spain), L. Feced (Valencia, Spain), L. Bouzas (Valencia, Spain), R. Amaro (Barcelona, Spain), V. Alcaraz (Barcelona, Spain), A. Torres (Barcelona, Spain), R. Menéndez (Valencia, Spain)

Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Méndez (Valencia, Spain), A. Moscardó (Valencia, Spain), A. Latorre (Valencia, Spain), A. Piró (Valencia, Spain), P. Gonzalez-Jimenez (Valencia, Spain), L. Feced (Valencia, Spain), L. Bouzas (Valencia, Spain), R. Amaro (Barcelona, Spain), V. Alcaraz (Barcelona, Spain), A. Torres (Barcelona, Spain), R. Menéndez (Valencia, Spain). Platelet activation correlates with disease severity in bronchiectasis. 2168

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021

Longitudinal serological assessment of neutrophil activity is related to disease progression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002

Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis
Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017
Year: 2018



A?-Val360: a marker of neutrophil elastase and COPD disease activity
Source: Eur Respir J 2013; 41: 31-38
Year: 2013



Evaluating disease severity in idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017
Year: 2017



Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Tumor-associated antigens in acute exacerbation of idiopathic pulmonary fibrosis: Associations with disease activity
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 226s
Year: 2007

Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001

Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease?
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Bronchiectasis  contributes to the severity of COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 31s
Year: 2004

Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009